MedPath

ROTEM in critically ill patients at risk for DIC

Recruiting
Conditions
Disseminated intravascular coagulation
Registration Number
NL-OMON22092
Lead Sponsor
Amsterdam UMC, location AMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Critically ill patients = 18 years of age with a clinical condition that is associated with a risk of developing DIC (e.g. severe infection, post-surgery severe infection, trauma, acute pancreatitis, tumors, hematologic malignancy).
- Platelet count < 150x10^9/

Exclusion Criteria

- No informed consent
- Active bleeding requiring transfusion
- No arterial catheter in situ
- Proven other cause of low platelet count (e.g. heparin induced thrombocytopenia)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cut off values of parameters of coagulation profiles as determined by ROTEM (speed and degree of clot formation, degree of fibrinolysis) corresponding to an ISTH DIC score of = 5 as the gold standard, DIC with bleeding, DIC with thrombotic events, bleeding and thrombotic events in critically ill patients at risk for DIC without an ISTH DIC diagnosis, and mortality.
Secondary Outcome Measures
NameTimeMethod
Distinguish patients based upon ROTEM profiles that may benefit from timely anticoagulant strategies<br>Compare ROTEM profiles and other parameters of coagulation between patients who have DIC due to different clinical risk factors<br>Determine a critical fibrinogen to nucleosome ratio that corresponds to the development of DIC and thrombosis <br>Relate nucleosome levels to other markers of endothelial activation and coagulation<br>Determine specific clinical risk factors for bleeding and thrombosis in DIC
© Copyright 2025. All Rights Reserved by MedPath